// App-Quantinova.ai

TCT-89 : Tradeoff between Myocardial Infarction and Bleeding in Relation to Bleeding Risk: insights from PARIS registry

Researchers

Presenter

  • Sabato Sorrentino

Principal Investigators

  • Usman Baber

  • Gennaro Giustino

  • Samantha Sartori

  • Serdar Farhan

  • Birgit Vogel

  • Jaya Chandrasekhar

  • Zhen Ge

  • Hannah Levine

  • David Cohen

  • Cono Ariti

  • C. Michael Gibson

  • Mitchell Krucoff

  • David Moliterno

  • Alaide Chieffo

  • Timothy Henry

  • Ioannis Iakovou

  • Antonio Colombo

  • Annapoorna Kini

  • Bernhard Witzenbichler

  • Philippe Gabriel Steg

  • Stuart Pocock

  • Roxana Mehran

Medical Centers

  • Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina, United States

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Mount Sinai Health System, New York, New York, United States

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • Helios Amper-Klinikum, Dachau, Germany

  • Unversity of Kentucky, Lexington, Kentucky, United States

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • Onassis Cardiac Surgery Center, Athens, Greece.

  • Groupe Hospitalier Bichat – Claude-Bernard, Paris, France

  • Interventional Cardiology Institute San Raffaele Hospital, Milan, Italy

  • Saint Luke's Mid America Heart Institute, Kansas City, Missouri, United States

  • Interventional Cardiology Institute San Raffaele Hospital - Stamford Hospital - Columbia University - Centro Cuore Columbus, Milan, Milan, Italy

  • Cedars Sinai Medical Center, Los Angeles, California, United States

Locations

  • United States

  • Germany

  • Italy

  • France

  • United Kingdom

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Anemia

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final